NEW YORK (GenomeWeb News) – Duke University plans to break up the Duke Institute for Genome Sciences and Policy into several new programs that will focus on science policy, applied genomics and precision medicine research, and genomics education, the university said yesterday.

Duke said its plan is to enable its genomics programs to evolve to keep up with the changing landscape of genomics-related fields in general. The faculty and staff from IGSP, which has reaped over $260 million in grant funding since it launched a decade ago, will be shifted into these new programs.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.